Evaluation of cardiovascular risk by growth-differentiation factor-15 and tissue Doppler imaging in children with subclinical hypothyroidism

被引:5
|
作者
Arslan, Derya [1 ]
Buyukinan, Muammer [2 ]
Uysal, Celil [3 ]
Deniz, Cigdem Damla [4 ]
机构
[1] Konya Training & Res Hosp, Univ Hlth Sci, Dept Pediat Cardiol, Konya, Turkey
[2] Konya Training & Res Hosp, Dept Pediat Endocrinol, Konya, Turkey
[3] Patnos State Hosp, Dept Pediat, Agri, Turkey
[4] Konya Training & Res Hosp, Dept Biochem, Konya, Turkey
关键词
Subclinical hypothyroidism; Cardiovascular risk; GDF-15; Child; HEART-FAILURE; GUIDELINES; ECHOCARDIOGRAPHY; ASSOCIATION; CHILDHOOD; HORMONE; DISEASE;
D O I
10.1007/s12020-019-01933-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Subclinical hypothyroidism, defined as increased TSH serum levels and normal serum free T4 concentrations, has been associated with an increased risk of heart disease in adults. But, data in children and adolescents are scanty and treatment of subclinical hypothyroidism is controversial. Growth differentiation factor-15 (GDF-15) is a promising biomarker of cardiac remodeling. This study aimed to evaluate the cardiovascular risk factors in children with subclinical hypothyroidism, measured with tissue Doppler echocardiography (TDE), and conventional echocardiography and GDF-15 level. Methods The study comprised a total of 41 pediatric patients with subclinical hypothyroidism (SH) (mean age 9.6 +/- 4.7 years) and 31 healthy children (mean age 11.2 +/- 3.4 years) as the control group. Subclinical hypothyroidism was defined as a thyroid-stimulating hormone level higher than 4 mIU/l and a normal free-thyroxine level (0.6-1.8 ng/dl). Tissue Doppler echocardiography was performed to all individuals in the control group and patient group at the beginning of the study. Global systolic function as assessed by left ventricular ejection fraction was compared between groups. The serum GDF-15 level was measured. Results There were no significant differences in demographic parameters between the SH and control groups. The left ventricular internal diameter end systole, interventricular septal end diastole, left ventricular posterior wall end diastole, and tricuspid annular plane systolic excursion values were significantly different between the SH and control groups (p = 0.038, 0.028, 0.005, and 0.000, respectively). The mean mitral isovolumic relaxation time value of the SH group was 57.2 +/- 9.3 ms, compared to 44.5 +/- 5.6 ms for the control group (p = 0.000). The mean tricuspid isovolumic contraction time value of the SH group was 58.7 +/- 9.4 ms, and that of the control group was 45.1 +/- 5.3 ms (p = 0.000). The mean tricuspid isovolumic relaxation time value of the SH group was 58.03 +/- 9.5 ms, and that of the control group was 45.1 +/- 5.3 ms (p = 0.000). There were no significant differences in the other m-mode or pulse Doppler echocardiography values between two groups. The GDF-15 value of the SH group was 382.6 +/- 268.2 pg/mL, and that of the control group was 473.6 +/- 337.9 pg/mL; this difference was not significant. Conclusion Patients with subclinical hypothyroidism versus healthy individuals had some changes in echocardiographic parameters that indicate involvement of diastolic function of the left ventricle. They were significantly different when compared SH group and the control group. This study demonstrated ventricle diastolic dysfunction in pediatric patients with hypothyroidism. The results of our study suggest that cardiac follow-up may be useful in patients with subclinical hypothyroidism and clinical trials are needed to explore therapeutic effects of T4 and T3 administration in this patients.
引用
收藏
页码:601 / 607
页数:7
相关论文
共 50 条
  • [31] Serum growth differentiation factor-15 (GDF-15) is a biomarker of cardiac manifestations in children with COVID-19
    Sally Raafat Ishak
    Mona Mostafa El Ganzoury
    Eman Mahmoud Fouda
    Maha Ahmad Anwar
    Amany Moustafa Kamal
    Heba Mostafa Hamza
    Nehad Ahmed Bakry
    European Journal of Medical Research, 28
  • [32] Serum growth differentiation factor-15 (GDF-15) is a biomarker of cardiac manifestations in children with COVID-19
    Ishak, Sally Raafat
    El Ganzoury, Mona Mostafa
    Fouda, Eman Mahmoud
    Anwar, Maha Ahmad
    Kamal, Amany Moustafa
    Hamza, Heba Mostafa
    Bakry, Nehad Ahmed
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [33] Growth-differentiation factor 15 as predictor of mortality in acute reperfused ST-elevation myocardial infarction: insights from cardiovascular magnetic resonance
    Eitel, Ingo
    Blase, Patrick
    Adams, Volker
    Hildebrand, Lysann
    Desch, Steffen
    Schuler, Gerhard
    Thiele, Holger
    HEART, 2011, 97 (08) : 632 - 640
  • [34] Evaluation of Arterial Stiffness Parameters and the Growth Differentiation Factor-15 Level in Patients with Premature Myocardial Infarction
    Dogan, Zekeriya
    Ileri, Cigdem
    Kay, Esin A.
    Sunbul, Murat
    Gurel, Emre Y.
    Sadic, Beste Oezben
    Sayar, Nurten
    Ergun, Tulin
    Tigen, Kursat M.
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (10):
  • [35] Associations of Circulating Growth Differentiation Factor-15 and ST2 Concentrations With Subclinical Vascular Brain Injury and Incident Stroke
    Andersson, Charlotte
    Preis, Sarah R.
    Beiser, Alexa
    DeCarli, Charles
    Wollert, Kai C.
    Wang, Thomas J.
    Januzzi, James L., Jr.
    Vasan, Ramachandran S.
    Seshadri, Sudha
    STROKE, 2015, 46 (09) : 2568 - 2575
  • [36] Growth Differentiation Factor 15 as a Biomarker of Cardiovascular Risk in Chronic Musculoskeletal Pain
    Leon-Gonzalez, Rocio
    Ortola, Rosario
    Carballo-Casla, Adrian
    Sotos-Prieto, Mercedes
    Buno-Soto, Antonio
    Rodriguez-Sanchez, Isabel
    Pastor-Barriuso, Roberto
    Rodriguez-Artalejo, Fernando
    Garcia-Esquinas, Esther
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2024, 79 (08):
  • [37] Methylation at CpG sites related to growth differentiation factor-15 was not prospectively associated with cardiovascular death in discordant monozygotic twins
    Moore, Spencer Shawn
    Mukherji, Pallavi
    Leung, Ming
    Vrentas, Catherine E.
    Mwanja, Melsa M.
    Dai, Jun
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [38] Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases
    Mueller, Thomas
    Leitner, Isabella
    Egger, Margot
    Haltmayer, Meinhard
    Dieplinger, Benjamin
    CLINICA CHIMICA ACTA, 2015, 445 : 155 - 160
  • [39] Growth differentiating factor-15 and its association with traditional cardiovascular risk factors: The African-PREDICT study
    Vermeulen, Bridget
    Schutte, Aletta E.
    Gafane-Matemane, Lebo F.
    Kruger, Ruan
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2020, 30 (06) : 925 - 931
  • [40] Growth differentiation factor 15 (GDF-15) as potential cardiovascular risk biomarker in antiphospholipid syndrome
    Tektonidou, Maria G.
    Papassotiriou, Ioannis
    Sfikakis, Petros P.
    RHEUMATOLOGY, 2022, 61 (01) : 394 - 399